444 related articles for article (PubMed ID: 16429482)
1. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
[TBL] [Abstract][Full Text] [Related]
2. NMR conformational studies of micelle-bound orexin-B: a neuropeptide involved in the sleep/awake cycle and feeding regulation.
Miskolzie M; Lucyk S; Kotovych G
J Biomol Struct Dyn; 2003 Dec; 21(3):341-51. PubMed ID: 14616030
[TBL] [Abstract][Full Text] [Related]
3. The NMR-derived conformation of orexin-A: an orphan G-protein coupled receptor agonist involved in appetite regulation and sleep.
Miskolzie M; Kotovych G
J Biomol Struct Dyn; 2003 Oct; 21(2):201-10. PubMed ID: 12956605
[TBL] [Abstract][Full Text] [Related]
4. Structural properties of orexins for activation of their receptors.
Lang M; Bufe B; De Pol S; Reiser O; Meyerhof W; Beck-Sickinger AG
J Pept Sci; 2006 Apr; 12(4):258-66. PubMed ID: 16138386
[TBL] [Abstract][Full Text] [Related]
5. Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction.
Putula J; Turunen PM; Johansson L; Näsman J; Ra R; Korhonen L; Kukkonen JP
FEBS Lett; 2011 May; 585(9):1368-74. PubMed ID: 21510948
[TBL] [Abstract][Full Text] [Related]
6. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness.
Ohno K; Sakurai T
Front Neuroendocrinol; 2008 Jan; 29(1):70-87. PubMed ID: 17910982
[TBL] [Abstract][Full Text] [Related]
7. Orexins and their receptors from fish to mammals: a comparative approach.
Wong KK; Ng SY; Lee LT; Ng HK; Chow BK
Gen Comp Endocrinol; 2011 Apr; 171(2):124-30. PubMed ID: 21216246
[TBL] [Abstract][Full Text] [Related]
8. Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection.
Bader R; Bettio A; Beck-Sickinger AG; Zerbe O
J Mol Biol; 2001 Jan; 305(2):307-29. PubMed ID: 11124908
[TBL] [Abstract][Full Text] [Related]
9. Requirement of intact disulfide bonds in orexin-A-induced stimulation of gastric acid secretion that is mediated by OX1 receptor activation.
Okumura T; Takeuchi S; Motomura W; Yamada H; Egashira Si S; Asahi S; Kanatani A; Ihara M; Kohgo Y
Biochem Biophys Res Commun; 2001 Feb; 280(4):976-81. PubMed ID: 11162621
[TBL] [Abstract][Full Text] [Related]
10. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
11. Conformation of a peptide ligand bound to its G-protein coupled receptor.
Inooka H; Ohtaki T; Kitahara O; Ikegami T; Endo S; Kitada C; Ogi K; Onda H; Fujino M; Shirakawa M
Nat Struct Biol; 2001 Feb; 8(2):161-5. PubMed ID: 11175907
[TBL] [Abstract][Full Text] [Related]
12. Structural similarities of micelle-bound peptide YY (PYY) and neuropeptide Y (NPY) are related to their affinity profiles at the Y receptors.
Lerch M; Mayrhofer M; Zerbe O
J Mol Biol; 2004 Jun; 339(5):1153-68. PubMed ID: 15178255
[TBL] [Abstract][Full Text] [Related]
13. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
[TBL] [Abstract][Full Text] [Related]
14. Orexin B inhibits proliferation and stimulates specialized function of cultured rat calvarial osteoblast-like cells.
Ziolkowska A; Rucinski M; Tyczewska M; Malendowicz LK
Int J Mol Med; 2008 Dec; 22(6):749-55. PubMed ID: 19020772
[TBL] [Abstract][Full Text] [Related]
15. Mapping of the binding sites for the OX1 orexin receptor antagonist, SB-334867, using orexin/hypocretin receptor chimaeras.
Putula J; Kukkonen JP
Neurosci Lett; 2012 Jan; 506(1):111-5. PubMed ID: 22079339
[TBL] [Abstract][Full Text] [Related]
16. Orexins (hypocretins) and adrenal function.
Jöhren O; Brüggemann N; Dominiak P
Horm Metab Res; 2004 Jun; 36(6):370-5. PubMed ID: 15241726
[TBL] [Abstract][Full Text] [Related]
17. Distinct recognition of OX1 and OX2 receptors by orexin peptides.
Ammoun S; Holmqvist T; Shariatmadari R; Oonk HB; Detheux M; Parmentier M; Akerman KE; Kukkonen JP
J Pharmacol Exp Ther; 2003 May; 305(2):507-14. PubMed ID: 12606634
[TBL] [Abstract][Full Text] [Related]
18. Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation.
Silveyra P; Lux-Lantos V; Libertun C
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E977-85. PubMed ID: 17638707
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and protein distribution of orexins and orexin receptors in rat retina.
Liu F; Xu GZ; Wang L; Jiang SX; Yang XL; Zhong YM
Neuroscience; 2011 Aug; 189():146-55. PubMed ID: 21621592
[TBL] [Abstract][Full Text] [Related]
20. Effects of orexins A and B on expression of orexin receptors and progesterone release in luteal and granulosa ovarian cells.
Cataldi NI; Lux-Lantos VA; Libertun C
Regul Pept; 2012 Oct; 178(1-3):56-63. PubMed ID: 22749989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
